acta diurna · run record
2026-10-23-medtech
23 October 2026 ·published
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | $0.0003 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "U.S. poised to issue rule subjecting Chinese biotech licensing deals to additional scrutiny": pass (1 redispatch) | "Treasury may restrict U.S. investment in Chinese biotech sector": pass (0 redispatch) | "Moderna and Merck cancer vaccine reduces melanoma recurrence risk by 42% in trial": pass (0 redispatch) | "FDA finalizes guidance on prescription drug use-related software, pharma rejoices": pass (2 redispatch) | $0.0795 |
| 03 | dispatch | anthropic/claude-sonnet-5 | pass | — | $0.0837 | |
| 04 | rounds | anthropic/claude-sonnet-5 | pass | — | $0.0317 | |
| 05 | illuminate-rounds | — | — | — | skipped: no FAL_KEY — "The Shield Grown From the Wound Itself" publishes without a plate | $0.0000 |
| the day's wage | $0.1952 | |||||